Suraksha Diagnostic Limited IPO
Suraksha Diagnostic Limited was a mainboard IPO in the Healthcare Service Provider sector, offered at ₹420–₹441 per share to raise ₹846 crore. The issue was subscribed 1.27× overall (QIBs 1.74×, NIIs 1.41×, retail 0.95×). It listed on 6 Dec 2024 at ₹438 and closed its first day at ₹417, a listing loss of -5.4% versus the ₹441 issue price. It now trades around ₹316 (-28.3% versus the issue price).
Frequently asked questions
- How many times was the Suraksha Diagnostic Limited IPO subscribed?
- The Suraksha Diagnostic Limited IPO was subscribed 1.27× overall — 1.74× in the QIB category, 1.41× among non-institutional investors, 0.95× in retail.
- What were the Suraksha Diagnostic Limited IPO listing gains?
- Suraksha Diagnostic Limited listed on 6 Dec 2024 at ₹438, closing its first day at ₹417 — a listing loss of -5.4% versus the ₹441 issue price.
- What were the retail allotment odds for the Suraksha Diagnostic Limited IPO?
- Retail was subscribed 0.95×, so a single-lot application had roughly a 100% chance of allotment — most applicants were allotted, and allotment was finalised on 4 Dec 2024.
- What was the price band and lot size of the Suraksha Diagnostic Limited IPO?
- The price band was ₹420–₹441 per share, with a minimum lot of 34 shares (₹14,994 at the upper band).
- Who were the registrar and lead manager for the Suraksha Diagnostic Limited IPO?
- KFin Technologies Limited was the registrar, and ICICI Securities was the book-running lead manager.